US Patent 10030058 Modulating gamma-C-cytokine activity
Patent 10030058 was granted and assigned to Bioniz, LLC on July, 2018 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10030058 Modulating gamma-C-cytokine activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
